Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages

Journal of Experimental Medicine

Volumn 187, Issue 7, 1998, Pages 1103-1111

  Subbramanian, Ramu A ^a   Kessous Elbaz, Allegria ^a   Lodge, Robert ^a   Forget, Janique ^a   Yao, Xiao Jian ^a   Bergeron, Dominique ^a   Cohen, Eric A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; REGULATOR PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MITOSIS INHIBITION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS TRANSCRIPTION;

CELL NUCLEUS; DNA REPLICATION; DNA, VIRAL; G2 PHASE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, VPR; HIV-1; HUMANS; MACROPHAGES; PHENOTYPE; RNA, VIRAL; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 0032489864     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.7.1103     Document Type: Article

References (48)

1. Arrigo, S.J., and I.S.Y. Chen. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:808-819.
2. Garrett, E.D., L.S. Tiley, and B.R. Cullen. 1991. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J. Virol. 65:1653-1657.
3. Tristem, M., C. Marshall, A. Karpas, J. Petrik, and F. Hill. 1990. Origin of vpx in lentiviruses. Nature. 347:341-342.
4. Tristem, M., C. Marshall, A. Karpas, and F. Hill. 1992. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO (Eur. Mol. Biol. Organ.) J. 11:3405-3412.
5. Balliet, J.W., D.L. Kolson, G. Eiger, F.M. Kim, K.A. McGann, A. Srinivasan, and R. Collman. 1994. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology. 200:623-631.
6. Balotta, C., P. Lusso, R. Crowley, R.C. Gallo, and G. Franchini. 1993. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 67:4409-4414.
7. Connor, R.I., K. Kuan Chen, S. Choc, and N. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology. 206:935-944.
8. Hattori, N., F. Michaels, K. Fargnoli, L. Marcon, R.C. Gallo, and G. Franchini. 1990. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA. 87: 8080-8084.
9. Westervelt, P., T. Henkel, D.B. Trowbridge, J. Orenstein, J. Heuser, H.E. Gendelman, and L. Ratner 1992. Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J. Virol. 66:3925-3931.
10. Cohen, E.A., E.F. Terwilliger, Y. Jalinoos, J. Proulx, J.G. Sodroski, and W.A. Haseltine. 1990. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 3: 11-18.
11. Heinzinger, N.K., M.I. Bukinsky, S.A. Haggerty, A.M. Ragland, V. Kewalramani, M.A. Lee, H.E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:7311-7315.
12. Gallay, P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
13. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:9825-9830.
14. He, J., S. Choe, R. Walker, P. Di Marzio, D.O. Morgan, and N.R. Landau. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69: 6705-6711.
15. Jowett, J.B., V. Planelles, B. Poon, N.P. Shah, M.L. Chen, and I.S. Chen. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
16. Planelles, V., J.B. Jowett, Q.X. Li, Y. Xie, B. Hahn, and I.S. Chen. 1996. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:2516-2524.
17. Re, F., D. Braaten, E.K. Franke, and J. Luban. 1995. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:6859-6864.
18. Rogel, M.E., L.I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
19. Stivahtis, G.L., M.A. Soares, M.A. Vodicka, B.H. Hahn, and M. Emerman. 1997. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71:4331-4338.
20. Beaulieu, S., A. Kessous, D. Landry, S. Montplaisir, D. Bergeron, and E.A. Cohen. 1996. In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type-1. Virology. 222:214-226.
21. Yao, X.J., R.A. Subbramanian, N. Rougeau, F. Boisvert, D. Bergeron, and E.A. Cohen. 1995. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69:7032-7044.
22. Lamarre, D., G. Croteau, E. Wardrop, L. Bourgon, D. Thibeault, C. Clouette, M. Vaillancourt, E.A. Cohen, C. Pargellis, C. Yoakim, and P.C. Anderson. 1997. Antiviral properties of Palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 41:965-971.
23. Hasse, A., L. Brahie, L. Stowring, and H. Blum. 1984. Detection of viral nucleic acids by in situ hybridization. Methods Virol. 7:189-226.
24. Cox, K.H., D.V. DeLeon, L.M. Angerer, and R.C. Angerer. 1984. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol. 101: 485-502.
25. Berrada, F., D. Ma, J. Michaud, G. Doucet, L. Giroux, and A. Kessous-Elbaz. 1995. Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alteration. J. Virol. 69:6770-6778.
26. Simon, J.H., and M.H. Malim. 1996. The human immunodeficiency virus type 1 vif protein modulates the postpenetration stability of viral nucleoprotein complex. J. Virol. 70: 5297-5305.
27. Jockers, R., A.D. Silva, A.D. Strosberg, M. Bouvier, and S. Marullo. 1996. New molecular and structural determinants involved in β2-adrenergic receptor desensitization and sequestration. Delineation using chimeric β3/β2-adrenergic receptors. J. Biol. Chem. 271:9355-9362.
28. Di Marzio, P., S. Choe, M. Ebright, R. Knoblauch, and N.R. Landau. 1995. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:7909-7916.
29. Mahalingam, S., V. Ayyavoo, M. Patel, T. Kieber-Emmons, and D.B. Weiner. 1997. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency vpr. J. Virol. 71:6339-6347.
30. Mahalingam, S., R.G. Collman, M. Patel, C.E. Monken, and A. Srinivasan. 1995. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology. 212:331-339.
31. Wang, L., S. Mukherjee, O. Narayan, and L.J. Zhao. 1996. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1. Gene. 178:7-13.
32. Zhao, L.-J., S. Mukherjee, and O. Narayan. 1994. Biochemical mechanism of HIV-1 vpr function: specific interaction with a cellular protein. J. Biol Chem. 289:15827-15832.
33. Trono, D., and P. Gallay. 1997. In response to Freed et al. Cell. 88:173-174.
34. Miller, M.D., MT. Warmerdam, I. Gaston, W.C. Greene, and M.B. Feinberg. 1994. The human immunodeficiency virus 1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:101-113.
35. Spina, C.A., T.J. Kwoh, M.Y. Chowers, J.C. Guatelli, and D.D. Richman. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179: 115-123.
36. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV Nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:569-576.
37. Schuitemaker, H., N.A. Koostra, M.H.G.M. Koppelman, S. Bruisten, H.G. Huisman, M. Tersmette, and F. Miedema. 1992. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1154-1160.
38. Emerman, M. 1996. HIV-1, Vpr and the cell cycle. Curr. Biol. 6:1096-1103.
39. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80: 379-388.
40. Levy, D.N., Y. Refaeli, R.R. MacGregor, and D.B. Weiner. 1994. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:10873-10877.
41. Levy, D.N., Y. Refaeli, and D.B. Weiner. 1995. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1243-1252.
42. Ayyavoo, V., A. Mahboubi, S. Mahalingam, R., Ramalingam, S. Kudchodkar, W.V. Willams, D.R. Green, and D.B. Weiner. 1997. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nat. Med. 3:1117-1123.
43. Wang, B., Y.C. Ge, F. Palasanthiran, S.H. Xiang, J. Ziegler, D.E. Dwyer, C. Randle, D. Dowton, A. Cunningham, and N.K. Saksena. 1996. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. Virology. 223:224-232.
44. Fletcher, T.M., 3rd, B. Brichacek, N. Sharova, M.A. Newman, G. Stivahtis, P.M. Sharp, M. Emerman, B.H. Hahn, and M. Stevenson. 1996. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes m HIV-2/SIV(SM). EMBO (Eur. Mol. Biol. Organ.) J. 15:6135-6165.
45. Subbramanian, R., and E.A. Cohen. 1994. Molecular biology of HIV accessory genes. J. Virol. 68:6831-6835.
46. Wooley, D.P., R.A. Smith, S. Czajak, and R.C. Desrosiers. 1997. Direct demonstration of retroviral recombination in rhesus monkey. J. Virol. 71:9650-9653.
47. Lang, S.M., M. Weeger, C. Stahl-Hennig, C. Coulibaly, G. Hunsmann, J. Muller, H. Muller-Hermelink, D. Fuchs, H. Wachter, M.M. Daniel, et al. 1993. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:902-912.
48. Folks, T.M., K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T cell clone. Proc. Natl. Acad. Sci. USA. 86:2365-2368.